Does Premera Blue Cross cover GLP-1s?
What Premera Blue Cross says on its own pages (premera.com), sorted by topic. Your own plan documents decide what you get.
Read Sep 28, 2026. Each line names the plan type it applies to.
Does it cover GLP-1s for weight loss?
- Premera’s Feb. 12, 2026 formulary newsletter says weight-management GLP-1s are only covered when the employer group has elected the weight-loss drug benefit.Employer and commercial plans:
Weight‑management GLP‑1s are reviewed under the weight‑loss drug policy and are only covered when an employer group has elected this benefit.
producernews.premera.com, Sep 29, 2026 - Premera’s Feb. 12, 2026 newsletter says that if a group does not elect weight-loss drug coverage, GLP-1s for obesity are not covered.Employer and commercial plans:
If a group does not elect weight‑loss drug coverage, GLP‑1s for obesity are not covered.
producernews.premera.com, Sep 29, 2026 - Premera says it exited Medicare Advantage: as of Jan. 1, 2025 it no longer offers Medicare Advantage plans.Medicare:
Premera Blue Cross has publicly announced the company will exit the Medicare Advantage market. As of January 1, 2025, Premera will no longer offer Medicare Advantage plans.
medicare.premera.com, Sep 29, 2026
Does it depend on your employer or plan?
- Premera’s Feb. 12, 2026 newsletter says it uses two GLP-1 coverage pathways depending on indication and employer group benefit design.Employer and commercial plans:
Premera uses two distinct policy pathways for GLP‑1 coverage, depending on indication and employer group benefit design.
producernews.premera.com, Sep 29, 2026 - Premera’s employer news (Aug. 22, 2023) says its drugs-for-weight-management policy applies to employer groups that chose to add weight-loss drug coverage.Employer and commercial plans:
The drugs for weight management policy applies for employer groups who’ve chosen to add weight-loss drug coverage.
premera.com, Sep 29, 2026
Prior authorization criteria
- Premera’s Feb. 12, 2026 newsletter says that for groups with the benefit, FDA-approved weight-loss GLP-1s such as Wegovy and Zepbound require prior authorization.Employer and commercial plans:
FDA‑approved weight‑loss GLP‑1s (e.g., Wegovy, Zepbound) require prior authorization
producernews.premera.com, Sep 29, 2026 - Premera’s June 11, 2026 producer news describes a new employer option, Access Select, with a BMI threshold of 35 for weight-loss GLP-1s, or BMI 27-34 plus two related health conditions.Employer and commercial plans:
Access Select manages cost while allowing coverage. It sets a BMI threshold of 35 for weight loss GLP‑1s. Members with a BMI of 27–34 must also have two related health conditions.
producernews.premera.com, Sep 29, 2026 - Premera’s Sept. 10, 2026 producer news lists, as one employer approach, targeted coverage for BMI 35 or greater, or BMI 27-34 with two or more weight-related conditions.Employer and commercial plans:
Targeted weight management coverage for members with a BMI of 35 or greater, or a BMI of 27-34 with two or more weight-related health conditions
producernews.premera.com, Sep 29, 2026 - Premera’s Sept. 10, 2026 producer news lists, as another employer approach, broader coverage for BMI 30 or greater, or BMI 27-34 with one or more weight-related conditions.Employer and commercial plans:
Broader weight management coverage eligibility for members with a BMI of 30 or greater, or a BMI of 27-34 with one or more weight-related health conditions
producernews.premera.com, Sep 29, 2026 - MASH: in pharmacy policy revisions effective Sept. 1, 2026 (Drugs for Weight Management 5.01.621, Premera Blue Cross / Premera HMO), Wegovy injection criteria were expanded to noncirrhotic MASH.Employer and commercial plans:
Wegovy (semaglutide) injection criteria expanded to include treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH).
premera.com, Sep 29, 2026
Sleep apnea (Zepbound)
- Premera’s June 11, 2026 producer news describes Clinical Select, an option for groups that do not cover weight-loss GLP-1s, covering FDA-approved conditions such as heart disease, sleep apnea and MASH/NASH.Employer and commercial plans:
Clinical Select supports members who need GLP‑1s for medical reasons, not weight loss. It’s designed for groups that don’t cover weight loss GLP‑1s today. Coverage includes FDA‑approved conditions such as heart disease, sleep apnea, and MASH/NASH.
producernews.premera.com, Sep 29, 2026
Heart risk (Wegovy)
- Premera’s Clinical Select option (June 11, 2026) covers GLP-1s for FDA-approved conditions including heart disease, for groups that do not cover weight-loss GLP-1s.Employer and commercial plans:
Clinical Select supports members who need GLP‑1s for medical reasons, not weight loss. It’s designed for groups that don’t cover weight loss GLP‑1s today. Coverage includes FDA‑approved conditions such as heart disease, sleep apnea, and MASH/NASH.
producernews.premera.com, Sep 29, 2026 - Premera’s Sept. 10, 2026 producer news lists an employer approach that provides GLP-1 access only for FDA-approved medical indications such as cardiovascular disease.Employer and commercial plans:
Provide access to GLP-1s for FDA-approved medical indications, such as cardiovascular disease
producernews.premera.com, Sep 29, 2026
Type 2 diabetes
- Premera’s Feb. 12, 2026 newsletter heading says GLP-1s for type 2 diabetes are covered across all plans.All plans:
GLP‑1s for Type 2 Diabetes (Covered Across All Plans)
producernews.premera.com, Sep 29, 2026 - Premera says its diabetes policy is standard across all plans and requires a diabetes diagnosis for GLP-1s approved for diabetes (employer news, Aug. 22, 2023).All plans:
The diabetes policy is standard across all plans and it outlines medical necessity criteria for GLP-1s approved for diabetes, including requiring a diabetes diagnosis.
premera.com, Sep 29, 2026
Recent changes
- Premera’s Feb. 12, 2026 newsletter (in its type 2 diabetes GLP-1 section) says updated quantity limits took effect Jan. 1, 2026.All plans:
Updated quantity limits went into effect on January 1, 2026, to support consistent, appropriate utilization.
producernews.premera.com, Sep 29, 2026 - Premera’s June 11, 2026 producer news says it created two new GLP-1 solutions for employers.Employer and commercial plans:
As GLP‑1 use grows, employers want options that better fit their goals. We’ve created two new solutions that support their population needs, risk tolerance and financial strategy.
producernews.premera.com, Sep 29, 2026 - In pharmacy policy revisions effective Sept. 1, 2026, Premera says Foundayo (orforglipron) criteria now give a 7-month initial approval period.Employer and commercial plans:
Foundayo (orforglipron) criteria now provide an initial approval period of 7 months.
premera.com, Sep 29, 2026
How to check your own plan
- Premera’s Rx Search page says members should check the 2026 drug lists for what is covered.All plans:
Our plans cover thousands of medications. Check our drug lists for what’s covered.
premera.com, Sep 29, 2026
What we could not confirm
- More detail, such as exact BMI cutoffs, is in 7 PDF documents from Premera Blue Cross, which we have not opened.
- 2 of its pages blocked automated reading.
Next steps
- Prior authorization and appeal letter templates
- Can you use the maker's savings card with your coverage?
- If it is not covered: the lowest verified cash prices
Other insurers: Aetna, Anthem Blue Cross and Blue Shield, Blue Cross and Blue Shield of Illinois, Blue Shield of California, Cigna, Florida Blue, Highmark, Humana, Independence Blue Cross, Kaiser Permanente, Molina Healthcare, Oscar Health, UnitedHealthcare, Ambetter, Wellcare, TRICARE, FEP Blue (federal employees), BlueCross BlueShield of South Carolina, CareFirst BlueCross BlueShield